1
|
Snider WD: Functions of the neurotrophins
during nervous system development: what the knockouts are teaching
us. Cell. 77:627–638. 1994. View Article : Google Scholar : PubMed/NCBI
|
2
|
Paul AB, Grant ES and Habib FK: The
expression and localisation of beta-nerve growth factor (beta-NGF)
in benign and malignant human prostate tissue: relationship to
neuroendocrine differentiation. Br J Cancer. 74:1990–1996. 1996.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Papatsoris AG, Liolitsa D and Deliveliotis
C: Manipulation of the nerve growth factor network in prostate
cancer. Expert Opin Investig Drugs. 16:303–309. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Arrighi N, Bodei S, Zani D, et al: Nerve
growth factor signaling in prostate health and disease. Growth
Factors. 28:191–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
McVary KT, McKenna KE and Lee C: Prostate
innervation. Prostate Suppl. 8:2–13. 1998. View Article : Google Scholar
|
6
|
Li C, Watanabe G, Weng Q, et al:
Expression of nerve growth factor (NGF), and its receptors TrkA and
p75 in the reproductive organs of the adult male rats. Zoolog Sci.
22:933–937. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Huang S, Fang X, Meng Y, et al:
Sympathetic nervous system overactivity in the Wistar rat with
proliferative lesions of ventral prostate induced by chronic
stress. Urol Int. 83:230–235. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Vaalasti A, Alho AM, Tainio H and Hervonen
A: The effect of sympathetic denervation with 6-hydroxydopamine on
the ventral prostate of the rat. Acta Histochem. 79:49–54. 1986.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Karp JD, Smith J and Hawk K: Restraint
stress augments antibody production in cyclophosphamide-treated
mice. Physiol Behav. 70:271–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Murphy RA, Watson AY and Rhodes JA:
Biological sources of nerve growth factor. Appl Neurophysiol.
47:33–42. 1984.PubMed/NCBI
|
11
|
Djakiew D, Delsite R, Pflug B, et al:
Regulation of growth by a nerve growth factor-like protein which
modulates paracrine interactions between a neoplastic epithelial
cell line and stromal cells of the human prostate. Cancer Res.
51:3304–3310. 1991.
|
12
|
Graham CW, Lynch JH and Djakiew D:
Distribution of nerve growth factor-like protein and nerve growth
factor receptor in human benign prostatic hyperplasia and prostatic
adenocarcinoma. J Urol. 147:1444–1447. 1992.PubMed/NCBI
|
13
|
Liu DT, Reid MT, Bridges DC and Rush RA:
Denervation, but not decentralization, reduces nerve growth factor
content of the mesenteric artery. J Neurochem. 66:2295–2299.
1996.PubMed/NCBI
|
14
|
Goda M, Atagi S, Amitani K, et al: Nerve
growth factor suppresses prostate tumor growth. J Pharmacol Sci.
112:463–466. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Golomb E, Rosenzweig N, Eilam R and
Abramovici A: Spontaneous hyperplasia of the ventral lobe of the
prostate in aging genetically hypertensive rats. J Androl.
21:58–64. 2000.PubMed/NCBI
|
16
|
Clemow DB, Steers WD, McCarty R and Tuttle
JB: Altered regulation of bladder nerve growth factor and neurally
mediated hyperactive voiding. Am J Physiol. 275:R1279–R1286.
1998.PubMed/NCBI
|
17
|
Kim JC, Park EY, Hong SH, et al: Changes
of urinary nerve growth factor and prostaglandins in male patients
with overactive bladder symptom. Int J Urol. 12:875–880. 2005.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Djakiew D: Dysregulated expression of
growth factors and their receptors in the development of prostate
cancer. Prostate. 42:150–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Dalal R and Djakiew D: Molecular
characterization of neurotrophin expression and the corresponding
tropomyosin receptor kinases (trks) in epithelial and stromal cells
of the human prostate. Mol Cell Endocrinol. 134:15–22. 1997.
View Article : Google Scholar
|